CLINICAL_TRIALS
withdrawal
· 2026-01-29
Clinical Trial Update: VAPorized Administration of Bumetanide for Outpatient Relief in Heart Failure [Phase 4]
Summary
A Phase 4 clinical trial of vaporized bumetanide for outpatient relief in heart failure has been withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Prisma Health-Upstate | Conditions: Heart Failure Congestive | Phase 4 | Status: WITHDRAWN